Tianshui Zhongxing Bio-technology Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,444.89 million compared to CNY 1,059.1 million a year ago. Revenue was CNY 1,444.89 million compared to CNY 1,059.1 million a year ago.

Net income was CNY 118.38 million compared to net loss of CNY 49 million a year ago. Basic earnings per share from continuing operations was CNY 0.3055 compared to basic loss per share from continuing operations of CNY 0.1356 a year ago. Diluted earnings per share from continuing operations was CNY 0.3055 compared to diluted loss per share from continuing operations of CNY 0.1356 a year ago.